March 4, 2026 · Form 4 insider transaction
Chambers Rebecca sold 13,941 shares of Veracyte, Inc. at $36.33 per share, a transaction worth $506.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.; Represents weighted average sales price. Sale prices for the transactions range from $36.01 to $36.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.